GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » 5-Year Yield-on-Cost %

Medlive Technology Co (HKSE:02192) 5-Year Yield-on-Cost % : 2.28 (As of May. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co 5-Year Yield-on-Cost %?

Medlive Technology Co's yield on cost for the quarter that ended in Dec. 2023 was 2.28.


The historical rank and industry rank for Medlive Technology Co's 5-Year Yield-on-Cost % or its related term are showing as below:

HKSE:02192' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.16   Med: 0.27   Max: 3.23
Current: 2.28


During the past 6 years, Medlive Technology Co's highest Yield on Cost was 3.23. The lowest was 0.16. And the median was 0.27.


HKSE:02192's 5-Year Yield-on-Cost % is ranked worse than
66.67% of 63 companies
in the Medical Distribution industry
Industry Median: 3.41 vs HKSE:02192: 2.28

Competitive Comparison of Medlive Technology Co's 5-Year Yield-on-Cost %

For the Medical Distribution subindustry, Medlive Technology Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's 5-Year Yield-on-Cost % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's 5-Year Yield-on-Cost % falls into.



Medlive Technology Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Medlive Technology Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Medlive Technology Co  (HKSE:02192) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Medlive Technology Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co (HKSE:02192) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.

Medlive Technology Co (HKSE:02192) Headlines

No Headlines